Literature DB >> 24838518

Females with FVIII and FIX deficiency have reduced joint range of motion.

Robert F Sidonio1, Fatima D Mili, Tengguo Li, Connie H Miller, William C Hooper, Michael R DeBaun, Michael Soucie.   

Abstract

Little is known about rates of joint bleeding among females with FVIII/FIX deficiency or hemophilia carriers. In a cross-sectional study, we tested the hypothesis that females with FVIII or FIX deficiency enrolled in the Universal Data Collection (UDC) project had a reduced mean overall joint range of motion (ROM) compared with historic controls from the Normal Joint Study. Demographics, clinical characteristics, and joint ROM measurements on 303 females without a bleeding disorder and 148 females with FVIII and FIX deficiency, respectively, between the ages of 2-69 years and a body mass index (BMI) ≤ 35 were compared. Multivariate linear regression was performed with the overall joint ROM (sum of the right and left ROM measurements of five joints) as the dependent variable and FVIII or FIX activity as the independent variable adjusting for age, race, BMI, and number of joint bleeds reported over the last 6 months. As FVIII and FIX activity decreased, the mean overall joint ROM became reduced and in most cases was significantly lower than that of the controls regardless of age and clinical hemophilia severity. Further investigation of reduced joint ROM as evidence of subclinical joint bleeding in females with FVIII and FIX deficiency is warranted.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24838518      PMCID: PMC4477796          DOI: 10.1002/ajh.23754

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  9 in total

1.  Range of motion measurements: reference values and a database for comparison studies.

Authors:  J M Soucie; C Wang; A Forsyth; S Funk; M Denny; K E Roach; D Boone
Journal:  Haemophilia       Date:  2010-11-11       Impact factor: 4.287

2.  Bleeding symptoms in carriers of hemophilia A and B.

Authors:  E P Mauser Bunschoten; J C van Houwelingen; E J Sjamsoedin Visser; P J van Dijken; A J Kok; J J Sixma
Journal:  Thromb Haemost       Date:  1988-06-16       Impact factor: 5.249

3.  US Hemophilia Treatment Center population trends 1990-2010: patient diagnoses, demographics, health services utilization.

Authors:  J R Baker; B Riske; J H Drake; A D Forsberg; R Atwood; M Voutsis; R Shearer
Journal:  Haemophilia       Date:  2012-07-30       Impact factor: 4.287

4.  Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women.

Authors:  C Ay; K Thom; F Abu-Hamdeh; B Horvath; P Quehenberger; C Male; C Mannhalter; I Pabinger
Journal:  Haemophilia       Date:  2009-09-16       Impact factor: 4.287

5.  Management of carriers and babies with haemophilia.

Authors:  A M Street; R Ljung; S A Lavery
Journal:  Haemophilia       Date:  2008-07       Impact factor: 4.287

6.  Bleeding in carriers of hemophilia.

Authors:  Iris Plug; Eveline P Mauser-Bunschoten; Annette H J T Bröcker-Vriends; Hans Kristian Ploos van Amstel; Johanna G van der Bom; Joanna E M van Diemen-Homan; José Willemse; Frits R Rosendaal
Journal:  Blood       Date:  2006-03-21       Impact factor: 22.113

7.  von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

Authors:  W L Nichols; M B Hultin; A H James; M J Manco-Johnson; R R Montgomery; T L Ortel; M E Rick; J E Sadler; M Weinstein; B P Yawn
Journal:  Haemophilia       Date:  2008-03       Impact factor: 4.287

8.  Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors.

Authors:  J Michael Soucie; Christy Cianfrini; Robert L Janco; Roshni Kulkarni; Julie Hambleton; Bruce Evatt; Angela Forsyth; Sue Geraghty; Keith Hoots; Tom Abshire; Randall Curtis; Ann Forsberg; Heather Huszti; Margaret Wagner; Gilbert C White
Journal:  Blood       Date:  2003-11-13       Impact factor: 22.113

9.  Both hemophilia health care providers and hemophilia a carriers report that carriers have excessive bleeding.

Authors:  Allison Paroskie; Olatunde Oso; Benjamin Almassi; Michael R DeBaun; Robert F Sidonio
Journal:  J Pediatr Hematol Oncol       Date:  2014-05       Impact factor: 1.289

  9 in total
  14 in total

1.  Gene Therapy for Inherited Bleeding Disorders.

Authors:  Valder R Arruda; Jesse Weber; Benjamin J Samelson-Jones
Journal:  Semin Thromb Hemost       Date:  2021-02-26       Impact factor: 4.180

2.  Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States.

Authors:  Connie H Miller; J Michael Soucie; Vanessa R Byams; Amanda B Payne; Robert F Sidonio; Tyler W Buckner; Christopher J Bean
Journal:  Haemophilia       Date:  2021-09-04       Impact factor: 4.263

3.  Total knee arthroplasty in patients with haemophilic arthropathy is effective and safe according to the outcomes at a mid-term follow-up.

Authors:  Rui Wang; Zhengming Wang; Yong Gu; Jingjing Zhang; Penghe Wang; Peijian Tong; Shuaijie Lv
Journal:  J Orthop Traumatol       Date:  2022-07-11

4.  Evaluation of factor VIII polymorphic short tandem repeat markers in linkage analysis for carrier diagnosis of hemophilia A.

Authors:  Sabina Shrestha; Sufang Dong; Zuhua Li; Zhuliang Huang; Fang Zheng
Journal:  Biomed Rep       Date:  2016-07-04

5.  A cross-sectional study of bleeding phenotype in haemophilia A carriers.

Authors:  Allison Paroskie; Dave Gailani; Michael R DeBaun; Robert F Sidonio
Journal:  Br J Haematol       Date:  2015-04-01       Impact factor: 6.998

6.  Women and girls with haemophilia and bleeding tendencies: Outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review.

Authors:  Ateefa Chaudhury; Robert Sidonio; Nisha Jain; Elisa Tsao; Justyna Tymoszczuk; Mariana Oviedo Ovando; Roshni Kulkarni
Journal:  Haemophilia       Date:  2020-12-24       Impact factor: 4.287

Review 7.  Genetic causes of haemophilia in women and girls.

Authors:  Connie H Miller; Christopher J Bean
Journal:  Haemophilia       Date:  2020-12-13       Impact factor: 4.263

8.  Occurrence rates of haemophilia among males in the United States based on surveillance conducted in specialized haemophilia treatment centres.

Authors:  John Michael Soucie; Connie H Miller; Brandi Dupervil; Binh Le; Tyler W Buckner
Journal:  Haemophilia       Date:  2020-04-24       Impact factor: 4.263

9.  Clot stability as a determinant of effective factor VIII replacement in hemophilia A.

Authors:  L Leong; I N Chernysh; Y Xu; D Sim; C Nagaswami; Z de Lange; S Kosolapova; A Cuker; K Kauser; J W Weisel
Journal:  Res Pract Thromb Haemost       Date:  2017-08-10

10.  Bone health in symptomatic carriers of haemophilia A: a protocol for a multicentre prospective matched-cohort study.

Authors:  Grace H Tang; Erin Norris; Jessica Petrucci; Paula D James; Adrienne Lee; Man-Chiu Poon; Georgina Floros; Laurence Boma-Fischer; Jerry Teitel; Rosane Nisenbaum; Michelle Sholzberg
Journal:  BMJ Open       Date:  2019-12-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.